NOTE 8 STOCKHOLDERS' EQUITY - Option activity (Details) (USD $)	12 Months Ended
Dec. 31, 2012 Y	Dec. 31, 2011	Dec. 31, 2010
Equity [Abstract]
Outstanding, beginning balance, shares	50,106,287	3,217,240	3,092,417
Granted, shares	37,485,000	48,070,000	1,087,700
Exercised, shares			(37,786)
Expired and forfeited, shares	(1,308,779)	(1,180,953)	(925,091)
Outstanding, ending balance, shares	86,282,508	50,106,287	3,217,240
Options exercisable at year end, shares	22,646,940	6,740,497	1,316,567
Options vested or expected to vest at year end, shares	85,471,879	49,434,997
Shares available for future grant at year end, shares	20,471,897	44,261,608	2,039,549
Outstanding, weighted average exercise price, beginning	$ 0.31	$ 1.49	$ 1.91
Granted, weighted average exercise price	$ 0.58	$ 0.26	$ 1.45
Exercised, weighted average exercise price			$ 1.24
Expired and forfeited, weighted average exercise price	$ 0.74	$ 1.63	$ 2.85
Outstanding, weighted average exercise price, ending	$ 0.42	$ 0.31	$ 1.49
Options exercisable at year end, weighted average exercise price	$ 0.38	$ 0.53	$ 1.72
Options vested or expected to vest, weighted average exercise price	$ 0.42	$ 0.31
Outstanding, weighted averge remaining contractual term (in years)	8.2
Options exercisable at year end, weighted averge remaining contractual term (in years)	7.13
Options vested or expected to vest, weighted averge remaining contractual term (in years)	8.2
Weighted-average fair value of stock options granted during the year	$ 0.46	$ 0.21	$ 1.39
Outstanding at end of year, intrinsic value	$ 14,555,918
Options exercisable at year end, intrinsic value	5,137,054
Options vested or expected to vest, intrinsic value	$ 14,466,053

Name:	us-gaap_EquityAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.